Who invested in Canton Biologics?
Canton Biologics's investors include SDIC Venture Capital.
Who invested in Canton Biologics
Funding summaryUpdated 26 Oct 2026
$41Mraised across 1 round since 2023, from 1 source
- Latest round
- Series C, $41MSept 2023
- Investors
- 1
The rounds
- Sept 2023
Founders and team
From Canton Biologics's own website: 2 founders, 5 on the team.
Dr. Xiao ShenFounder and CEO
Dr. Hans BaumeisterCo-founder and Co-Managing Director of FyoniBio
- Dr. Songkai LiuSenior Vice President, Business Development
- Dr. Yue HanVice President, PM, RA and Marketing
- Qingkun WeiVice President, CDMO Operations
- Dr. Guangcai RenHead of Animal Health Business
- Dr. Ying YangHead of Bio-Health Business
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Canton Biologics
How much has Canton Biologics raised?
Canton Biologics has raised $41M across 1 round since 2023.
When did Canton Biologics last raise?
Canton Biologics's most recent round was a Series C of $41M in Sept 2023.
What was Canton Biologics's biggest round?
Its most recent round, $41M in Sept 2023, is also its largest on record.
Who backed Canton Biologics first?
Canton Biologics's first round on record, in Sept 2023, was backed by SDIC Venture Capital.
What stage is Canton Biologics at?
Canton Biologics's latest named round is a Series C, in Sept 2023.
Companies like Canton Biologics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.